Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03014570 · ClinicalTrials.gov registry record · NA
Testing the Implementation of EIT-4-BPSD
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 553
- Enrollment target
NCT03014570: Completed NA study, sponsored by University of Maryland, Baltimore.
NCT03014570 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 553 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03014570, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 553 participants
- Enrollment target
Study Summary
This pragmatic trial focuses on implementation of an evidence based process to increase person-centered management of behavioral and psychological symptoms of dementia (BPSD) in nursing homes, referred to as EIT-4-BPSD. The findings from this study will add to what is known about implementation of effective interventions in nursing homes, will serve as a model for other programs and care approaches, and will help facilities and staff implement quality person-centered care, which is the goal of the National Partnership to Improve Dementia Care and Reduce Antipsychotic Use in Nursing Homes.
Primary Outcome
The Barthel index has a score range of 0-100 with higher scores indicating higher physical function
Interventions
- BEHAVIORAL EIT-4-BPSD
- BEHAVIORAL Education-only Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 553 participants |
| Start Date | 2016-04 |
| Est. Completion | 2021-06-01 |
| Phase | NA |
What the finished NCT03014570 record still lists
NCT03014570 is an interventional study that assigns participants to a tested intervention. The registered 553 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 2 interventions - of which EIT-4-BPSD is the first listed.
NCT03014570 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03014570 about?
NCT03014570 is a clinical study titled "Testing the Implementation of EIT-4-BPSD". This pragmatic trial focuses on implementation of an evidence based process to increase person-centered management of behavioral and psychological symptoms of dementia (BPSD) in nursing homes, referred to as EIT-4-BPSD. The findings from this study will add to what is known about implementation of e...
What is the current status of trial NCT03014570?
This trial is currently completed. It is a NA study. The enrollment target is 553 participants. The study started on 2016-04. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03014570?
The interventions under investigation include: EIT-4-BPSD (BEHAVIORAL), Education-only Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT03014570?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03014570's enrollment target sits among peer trials
553 184th of 2000 higher than 1,817 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05786924 · 554 participants · Phase 1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NCT06217809 · 552 participants · NA
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
- NCT07146022 · 552 participants · Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- NCT06799000 · 555 participants · Phase 3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia